Stanford University
Showing 19,061-19,080 of 36,223 Results
-
Lu Lu
Postdoctoral Scholar, Mechanical Engineering
BioDr. Lu Lu is currently a postdoctoral researcher at Stanford University. He received his B.S. and Ph.D. degrees from Ningbo University and Shanghai University in China in 2014 and 2019, respectively. He then worked as a postdoctoral researcher at Peking University from 2020 to 2022 before joining Stanford. His research interests focus on solid mechanics, with emphasis on mechanical instabilities, deployable structures, mechanics of intelligent soft materials, plate and shell theories, and nonlocal elasticity. He has published nearly 30 peer-reviewed papers in journals such as PNAS, JMPS, IJSS, AMR, IJMS, JAM, and PRSA, and received the ASME Melville Medal in 2024.
-
Pan Lu
Postdoctoral Scholar, Biomedical Data Sciences
Current Research and Scholarly InterestsMy research goal is to build machines that can reason and collaborate with humans for the common good. My primary research focuses on machine learning and NLP, particularly machine reasoning, mathematical reasoning, and scientific discovery:
1. Mathematical reasoning in multimodal and knowledge-intensive contexts
2. Tool-augmented large language models for planning, reasoning, and generation
3. Parameter-efficient fine-tuning for fondation models
4. AI for scientific reasoning and discovery -
Sydney X. Lu
Assistant Professor of Medicine (Hematology)
BioSydney Lu is an assistant professor and physician-scientist in the Division of Hematology, Department of Medicine with a broad interest in both normal and abnormal RNA processing in the context of normal physiology and disease states. The laboratory studies translational questions regarding the mechanistic basis of RNA processing abnormalities in malignant blood disorders, their implications for leukemogenesis and cancer biology, as well as resultant therapeutic opportunities.
As a physician, Sydney’s group is particularly focused on dissecting RNA processing abnormalities in primary patient samples and disease-relevant preclinical model systems. Lab members employ a variety of ‘wet-lab’ and computational approaches to study transcriptome abnormalities in (1) states of immune dysfunction, (2) myeloid blood cancers such as myelodysplastic syndromes and acute myeloid leukemia, and (3) lymphoid blood cancers such as chronic lymphocytic leukemia. Additional projects are focused on novel therapeutics, including multiple targeted agents which modulate RNA processing, for the selective treatment of these diseases.
Sydney’s research is/has been supposed by grant funding from the National Cancer Institute, Parker Institute for Cancer Immunotherapy, Leukemia & Lymphoma Society, Aplastic Anemia & Myelodysplastic Syndromes International Foundation, the American Society for Clinical Oncology, the American Society of Hematology, the American Association for Cancer Research, the Paula and Rodger Riney Foundation, the Doris Duke Charitable Foundation, The Gabrielles Angel Foundation for Cancer Research, and the Stanford Cancer Institute.
